A detailed history of Lvw Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lvw Advisors, LLC holds 792 shares of VRTX stock, worth $397,362. This represents 0.05% of its overall portfolio holdings.

Number of Shares
792
Previous 742 6.74%
Holding current value
$397,362
Previous $347,000 6.05%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$460.0 - $505.78 $23,000 - $25,289
50 Added 6.74%
792 $368,000
Q2 2024

Jul 15, 2024

BUY
$392.81 - $485.53 $50,672 - $62,633
129 Added 21.04%
742 $347,000
Q1 2024

Apr 17, 2024

BUY
$407.69 - $446.08 $249,913 - $273,447
613 New
613 $256,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lvw Advisors, LLC Portfolio

Follow Lvw Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.